Vaccine developed
Scientists in The Netherlands have identified a potential vaccine for the deadly chikungunya virus (CHIKV) that has spread to Europe recently.
Scientists in The Netherlands have identified a potential vaccine for the deadly chikungunya virus (CHIKV) that has spread to Europe recently.
CHIKV is a mosquito-borne virus behind epidemics in Africa, South-East Asia and India, which has recently emerged in Europe through Asian tiger mosquitoes. Symptoms of the virus include joint pain, vomiting and nausea, headaches, chills and fever, as well as skin rashes.
The study, published in the Virology Journal,1 investigated the expression of individual CHIKV E1 and E2 glycoproteins in insect cells as well as developing purification methods for secreted forms of these glycoproteins. The study used metal affinity chromatography and confocal laser scanning microscopy to identify and obtain purified, glycosylated and secreted CHIKV E2. CHIKV E2 induces neutralizing antibodies in rabbits, which, according to the study, “underscores the potential use of E2 in a subunit vaccine to prevent CHIKV infections.”
1. S.W. Metz, Virology Journal, 8(353) (2011).
A Matrix-Matched Semiquantification Method for PFAS in AFFF-Contaminated Soil
Published: April 14th 2025 | Updated: April 14th 2025Catharina Capitain and Melanie Schüßler from the Faculty of Geosciences at the University of Tübingen, Tübingen, Germany describe a novel approach using matrix-matched semiquantification to investigate per- and polyfluoroalkyl substances (PFAS) in contaminated soil.
Silvia Radenkovic on Building Connections in the Scientific Community
April 11th 2025In the second part of our conversation with Silvia Radenkovic, she shares insights into her involvement in scientific organizations and offers advice for young scientists looking to engage more in scientific organizations.
